789 related articles for article (PubMed ID: 29263206)
1. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
[TBL] [Abstract][Full Text] [Related]
2. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
[TBL] [Abstract][Full Text] [Related]
3. Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop.
Rockstroh A; Moges B; Barzon L; Sinigaglia A; Palù G; Kumbukgolla W; Schmidt-Chanasit J; Sarno M; Brites C; Moreira-Soto A; Drexler JF; Ferreira OC; Ulbert S
Emerg Microbes Infect; 2017 Nov; 6(11):e99. PubMed ID: 29116222
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing Secondary Dengue Virus Infection From Zika Virus Infection With Previous Dengue by a Combination of 3 Simple Serological Tests.
Tsai WY; Youn HH; Brites C; Tsai JJ; Tyson J; Pedroso C; Drexler JF; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
Clin Infect Dis; 2017 Nov; 65(11):1829-1836. PubMed ID: 29020159
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of IgG Depletion in a Neutralization Assay Facilitates Differential Diagnosis of Zika and Dengue in Secondary Flavivirus Infection Cases.
Calvert AE; Boroughs KL; Laven J; Stovall JL; Luy BE; Kosoy OI; Huang CY
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618505
[TBL] [Abstract][Full Text] [Related]
6. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.
van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH
J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research.
Low SL; Leo YS; Lai YL; Lam S; Tan HH; Wong JCC; Tan LK; Ng LC
PLoS One; 2021; 16(1):e0244601. PubMed ID: 33497414
[TBL] [Abstract][Full Text] [Related]
8. Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population.
Zaidi MB; Cedillo-Barron L; González Y Almeida ME; Garcia-Cordero J; Campos FD; Namorado-Tonix K; Perez F
Acta Trop; 2020 Jan; 201():105201. PubMed ID: 31562846
[TBL] [Abstract][Full Text] [Related]
9. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections.
Furuya AKM; Hunt D; George KS; Dupuis AP; Kramer LD; Shi PY; Wong S
Clin Sci (Lond); 2019 Apr; 133(7):859-867. PubMed ID: 30902827
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections.
Tsai WY; Driesse K; Tsai JJ; Hsieh SC; Sznajder Granat R; Jenkins O; Chang GJ; Wang WK
Emerg Microbes Infect; 2020 Dec; 9(1):1722-1732. PubMed ID: 32684139
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.
Chao DY; Whitney MT; Davis BS; Medina FA; Munoz JL; Chang GJ
J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30541932
[TBL] [Abstract][Full Text] [Related]
12. Combination of Nonstructural Protein 1-Based Enzyme-Linked Immunosorbent Assays Can Detect and Distinguish Various Dengue Virus and Zika Virus Infections.
Tyson J; Tsai WY; Tsai JJ; Brites C; Mässgård L; Ha Youn H; Pedroso C; Drexler JF; Stramer SL; Balmaseda A; Harris E; Wang WK
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30429254
[TBL] [Abstract][Full Text] [Related]
13. Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.
Gallichotte EN; Young EF; Baric TJ; Yount BL; Metz SW; Begley MC; de Silva AM; Baric RS
mBio; 2019 Sep; 10(5):. PubMed ID: 31530669
[TBL] [Abstract][Full Text] [Related]
14. High specificity and sensitivity of Zika EDIII-based ELISA diagnosis highlighted by a large human reference panel.
Denis J; Attoumani S; Gravier P; Tenebray B; Garnier A; Briolant S; de Laval F; Chastres V; Grard G; Leparc-Goffart I; Coutard B; Badaut C
PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007747. PubMed ID: 31539394
[TBL] [Abstract][Full Text] [Related]
15. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
[TBL] [Abstract][Full Text] [Related]
16. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J
Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Anti-Dengue and Anti-Zika IgG on a Plasmonic Gold Platform with Neutralization Testing.
Rojas A; Natrajan MS; Weber J; Cardozo F; Cantero C; Ananta JS; Kost J; Tang M; López S; Bernal C; Guillén Y; Mendoza L; Páez M; Pinsky BA; Waggoner JJ
Am J Trop Med Hyg; 2021 Mar; 104(5):1729-1733. PubMed ID: 33782214
[TBL] [Abstract][Full Text] [Related]
18. Delayed and highly specific antibody response to nonstructural protein 1 (NS1) revealed during natural human ZIKV infection by NS1-based capture ELISA.
Gao X; Wen Y; Wang J; Hong W; Li C; Zhao L; Yin C; Jin X; Zhang F; Yu L
BMC Infect Dis; 2018 Jun; 18(1):275. PubMed ID: 29898684
[TBL] [Abstract][Full Text] [Related]
19. Development of Zika Virus Serological Testing Strategies in New York State.
Lee WT; Wong SJ; Kulas KE; Dupuis AP; Payne AF; Kramer LD; Dean AB; St George K; White JL; Sommer JN; Ledizet M; Limberger RJ
J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263203
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.
Montoya M; Collins M; Dejnirattisai W; Katzelnick LC; Puerta-Guardo H; Jadi R; Schildhauer S; Supasa P; Vasanawathana S; Malasit P; Mongkolsapaya J; de Silva AD; Tissera H; Balmaseda A; Screaton G; de Silva AM; Harris E
J Infect Dis; 2018 Jul; 218(4):536-545. PubMed ID: 29618091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
